α-Gustducin knockout mice did not gain as much weight as WT mice on HFD. Intragastric administration of bitter agonists caused further weight loss via α-gustducin pathway. Therefore, α-gustducin is involved in induction of obesity during HFD. The gene discussed is GNAT3; the disease is obesity disorder.